Chill out Harvett. It's phase 1 mate.
I don't know if you seriously believe what you are throwing up here, or are perhaps limited in your knowlege of pharma regs, drug development processes and the Herculean requirements involved in putting these formulations into, well...people. Or maybe "google" was playing up today?
These results are promising enough, certainly, to continue to phases II > on.
6 month progression free survival endpoints / SD (stable disease) for cytostatic therapies have delivered numerous billion dollar therapies.
Could this be one? Far too early to tell.
DYOR out there ppl.
- Forums
- ASX - By Stock
- NOX
- Ann: Veyonda and Radiotherapy Delivers Clinical Benefits
Ann: Veyonda and Radiotherapy Delivers Clinical Benefits, page-19
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
|
|||||
Last
9.6¢ |
Change
0.004(4.35%) |
Mkt cap ! $28.05M |
Open | High | Low | Value | Volume |
9.2¢ | 9.6¢ | 9.1¢ | $19.55K | 208.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10016 | 9.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.6¢ | 11899 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10016 | 0.094 |
1 | 5440 | 0.092 |
2 | 54710 | 0.090 |
1 | 100000 | 0.086 |
1 | 70000 | 0.083 |
Price($) | Vol. | No. |
---|---|---|
0.096 | 11899 | 1 |
0.099 | 48600 | 3 |
0.100 | 327884 | 4 |
0.105 | 35663 | 2 |
0.110 | 3550 | 1 |
Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online